materials. Diazotization in presence of NaN 3 and followed by cyclisation esterification with absolute methanol and followed by reduction with NaBH 4 and oxidation with NaOCl and NaBr in presence of 2, 2, 6, 6-tetramethyl-1-piperinyloxy 
Introduction

Triazoles are an important class of bioactive molecules having a wide spectrum of biological activities. A large number of 1, 2, 3-triazole derivatives have been reported to be synthetic intermediates and pharmaceuticals
. [4] [5] [6] [7] , antimicrobial compounds 8 , selective adrenergic receptor agonists 9 , kinase inhibitors [10] [11] , and other enzyme inhibitors [12] [13] .These observations prompted us to synthesize the title compounds with presumption that incorporation of amines and triazole nuclei would produce new compounds with significant antibacterial and anti-inflammatory activity.
Several therapeutically interesting 1, 2, 3-traizoles have been reported, including anti-HIV agents
Anti microbial activity:
The synthesized compounds were tested for their antibacterial activity by cup 
Anti inflammatory activity:
All the synthesized compounds were screened for anti-inflammatory activity by carrageen an induced rat paw edema method of winter et al 14 
III.
Results -1-(4-methylphenyl)-1H-1,2,3-triazole-4yl]methyl}methyl}-1(-) 
Analytical data of the above compounds: N-{[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazole-4yl]methyl}methyl cyclohexanamine (6a):
N-{[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazole-4yl]methyl}methyl}-1-(+)phenyl ethanamine (6b):This
N-{[5-methyl
N-{[5-methyl-1-(4-methoxyphenyl)-1H-1,2,3-triazole-4yl]methyl}methyl cyclohexanamine (6d):
This N-{[5-methyl-1-(4-methoxyphenyl)-1H-1,2,3-triazole-4yl] s, 3H, OCH 3 ), 3.99-4.167 (s, 2H, CH 2 ), 7.00-7.22 (s, 2H, Ar-H), 7.33-7.48 (m, 3H, Ar-H), 7.82-7.84 (d,  2H, Ar-H),10.17 (s, 1H, Ar-H), 10.38 (s, 1H, Ar-H)   (1S)-N-{[5-methyl-1-(4-methoxyphenyl)-1H-1 (2H, m, Ar-H), 7.278 (2H, d, Ar-H), 7.31-7.429 (5H, m, Ar-H), 1.40-1.44 (3H, m, CH 3 ), 0.93 (s, 1H, CH),  3.87-3.92 (t, 3H, CH 3 ), 2.26 (s, 3H, OCH 3 ), 1.40-1.44 (t, 3H, CH 3 ) 5-methyl-1, 4-disubstituted-1H-1,2,3 
TABLE 1 Physical data of
IV. Conclusion:
Among the compounds tested (6a) and (6b) exhibited mild activity against Bacillus subtillis , Staphylococcus aureus and compounds (6d) , (6e) exhibited mild activity against Staphylococcus aureus and Pseudomonas aeruginosa at a concentration of 1000 µg/50µl compared with the standard drug ciprofloxacin (10µg/50µl).None of the compounds have shown any activity against fungal strains Candida albicans and Saccharomyces cerevisiae at a concentration of 1000µg/50µl.In anti-inflammatory screening the compounds (6a),(6b),(6d),(6e) have shown good anti-inflammatory activity at a concentration of 100 mg/kg compared with the standard drug ibuprofen(100mg/kg).Therefore, these compounds can be further exploited to get lead compounds.
